BioLASCO Taiwan Co., Ltd.

NT$28.40As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6662Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (2.85%)
Div yield 5.28%
ROE 9.56%
Biotechnology
Beta (5Y) 0.16
PE TTM 17.86
TSR TTM (6.21%)
Mkt cap NT$727.4M
ROIC 10.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$34
18.37%
(77.70%)
Buy 11|8|8|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.56
0.62
0.69
0.69
12.43%
19.78%
21.91%
24.98%
RevenueNT$M
37.00
36.37
37.99
37.07
9.36%
8.54%
10.55%
2.80%
Peers (US$21.97M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.547
0.647
0.642
EBIT/Intx
1.829
0.165
0.161
Own earn%
(13.50)
(3.77)
(3.78)
Sh yield%
11.58
38.19
35.84
Owners
Insiders/Inst%
1.28
21.16
Short interest%
2.63
SBC / revenue%
2.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
6